AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.49%34.650.9%$1168.91m
JNJJohnson & Johnson
0.62%131.350.7%$908.58m
MRKMerck & Co., Inc.
1.92%85.060.6%$797.24m
BMYBristol-Myers Squibb Company
2.67%46.971.4%$680.66m
ABBVAbbVie, Inc.
2.30%64.432.3%$610.53m
LLYEli Lilly and Company
0.24%110.491.0%$456.04m
NVSNovartis AG Sponsored ADR
0.99%89.460.2%$209.31m
AZNAstraZeneca PLC Sponsored ADR
0.39%44.351.2%$166.53m
GSKGlaxoSmithKline plc Sponsored ADR
0.60%40.200.3%$95.35m
NVONovo Nordisk A/S Sponsored ADR Class B
2.70%51.650.1%$81.50m
SNYSanofi Sponsored ADR
0.89%42.020.2%$56.34m
LCILannett Company, Inc.
4.31%6.7736.6%$10.92m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.37%1.941.6%$3.62m
EPIXESSA Pharma Inc
3.28%1.510.1%$0.03m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.